Professor, IU School of Medicine; Medical Director, Pathology and Labs IU Health North Hospital
Pathology
Dr. Helen Michael, MD
|
|
Give Review
Helen Michael, MD practices Pathology. She researched medicine at Washington University School of Medicine in St. Louis. Helen Michael is also published. She has 14 publications published. The lastest publication: "Randomized Phase III Trial of Gemcitabine Plus Docetaxel Plus Bevacizumab or Placebo As First-Line Treatment for Metastatic Uterine Leiomyosarcoma: An NRG Oncology/Gyn...'
Publications
- Bevacizumab for advanced cervical cancer: patient-reported outcomes of a randomised, phase 3 trial (NRG Oncology-Gynecologic Oncology Group protocol 240).
- Randomized Phase III Trial of Gemcitabine Plus Docetaxel Plus Bevacizumab or Placebo As First-Line Treatment for Metastatic Uterine Leiomyosarcoma: An NRG Oncology/Gyn...
- Improved survival with bevacizumab in advanced cervical cancer.
- A randomized phase III trial of IV carboplatin and paclitaxel à 3 courses followed by observation versus weekly maintenance low-dose paclitaxel in patients with early-...
- Advanced stage mucinous adenocarcinoma of the ovary is both rare and highly lethal: a Gynecologic Oncology Group study.
- Molecular alterations in the pathogenesis of endometrial adenocarcinoma. Therapeutic implications.
- Chromosome 12p abnormalities in dysgerminoma of the ovary: a FISH analysis.
- Expression of CD117 (c-kit) receptor in dysgerminoma of the ovary: diagnostic and therapeutic implications.
- Fluorescence in situ hybridization analysis of chromosome 12p in paraffin-embedded tissue is useful for establishing germ cell origin of metastatic tumors.
- OCT4: a novel biomarker for dysgerminoma of the ovary.
- Identical allelic losses in mature teratoma and other histologic components of malignant mixed germ cell tumors of the testis.
- Studies of apurinic/apyrimidinic endonuclease/ref-1 expression in epithelial ovarian cancer: correlations with tumor progression and platinum resistance.
- A phase II trial of radiation therapy and weekly cisplatin chemotherapy for the treatment of locally-advanced squamous cell carcinoma of the vulva: A gynecologic oncol...
Doctors Specialties
- Anatomic Pathology
- Clinical Pathology
- Pathology
Accepted Insurances
Education
-
Washington University - Barnes-Jewish Hospital -
Washington University School of Medicine in St. Louis
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1508819616 |
| Last Name Of The Provider | MICHAEL |
| First Name Of The Provider | HELEN |
| View All |
Similar Doctors
|
|
Dr. Jon D. Rahman, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Jeffrey R. Mossler, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Glenn R. Schwenk Jr., MD
This Doctor is OpenDoctor Recommended.
|